Taking Iron Every Other Day: Absorption, Ferritin, and Two Different Answers
Primary research located and verified via PubMed.
Iron supplements have a reputation, and most of it is earned. They can be rough on the stomach, the advice about when to take them keeps changing, and plenty of people give up before their ferritin level has changed at all. A research group at ETH Zurich has spent about a decade on one specific question inside that mess: does the schedule change how much iron actually gets absorbed?
What the Zurich isotope studies measured
In the study the AANP digest picked up, 19 women with iron-deficiency anaemia took either 100 mg or 200 mg of iron as ferrous sulfate, tagged with stable iron isotopes, at 8 AM on days 2, 3, and 5 [1]. Stable isotopes are non-radioactive forms of iron that let researchers trace each specific dose through the body. Days 2 and 3 are consecutive; day 5 comes after a day off. Sixteen days later the researchers measured how much of each labelled dose had been incorporated into red blood cells, then repeated the whole sequence with the other dose.
The researchers found the same pattern at both doses. Serum hepcidin was higher on day 3, the second consecutive day, than on either day 2 or day 5. Hepcidin is the hormone that restricts how much iron the gut lets through, and a dose of oral iron raises it for roughly 24 hours. Fractional absorption on days 2 and 5 was 40 to 50% higher than on day 3, while absorption on day 2 was not significantly different from day 5. Fractional absorption is the share of a dose that the body actually takes in. Taking a second dose the very next morning meant absorbing a smaller share of it, because the previous dose had already raised hepcidin. The researchers also reported that total absorption from a single 200 mg dose on alternate days was about twice that from 100 mg on consecutive days, with no significant difference in gastrointestinal side effects between the two doses (p = 0.105).
This built on two earlier randomized trials in women who were iron-depleted without being anaemic [2]. At 60 mg, cumulative fractional absorption was 21.8% on alternate days against 16.3% on consecutive days (p = 0.0013), and cumulative total absorption was 175.3 mg against 131.0 mg (p = 0.0010). Splitting a daily dose into morning and evening halves produced no absorption advantage at all and raised hepcidin. Those authors wrote that their findings needed confirmation in anaemic patients, and the 2019 study is that confirmation.
Then the same group tested the schedule over six months
Absorption is a measurement rather than a clinical outcome. So the same group carried out a double-blind, placebo-controlled trial in 150 Swiss women with ferritin at or below 30 µg/L [3]. Ferritin is the protein that stores iron, and its blood level is the test most clinicians use to estimate iron stores. One group took 100 mg of iron daily for 90 days, then placebo for 90 days. The other took 100 mg on alternate days for 180 days. Both groups received the same total amount of iron.
At equal total dose, median serum ferritin came out at 44.8 µg/L on the alternate-day schedule and 43.8 µg/L on the consecutive-day schedule (p = 0.98). The better absorption did not produce more stored iron.
The groups did differ on two other measures. Gastrointestinal side effects on dosing days were substantially more common on the consecutive-day schedule (longitudinal prevalence ratio 1.56, 95% CI 1.38 to 1.77). That ratio compares how frequently side effects were reported on dosing days in each group, and a ratio of 1.0 would mean no difference. Hepcidin was lower on alternate days. At six months, 3.0% of the alternate-day group were still iron deficient against 11.4% of the consecutive-day group (p = 0.049), though at three months the two groups were indistinguishable (5.5% versus 4.3%, p = 0.74).
So the argument for alternate-day dosing comes from tolerability and from that six-month deficiency result, rather than from refilling iron stores any faster. And the six-month result is a secondary outcome with a p value just under 0.05, so I treat it as suggestive rather than settled.
Acid suppression, and the question a schedule cannot answer
Changing the schedule makes a small difference, and it does nothing about whatever made somebody iron deficient in the first place.
The cause I want to name specifically, because it is common and frequently missed, is acid suppression. Stomach acid is needed to free non-heme iron from food. Non-heme iron is the form found in plant foods and in most iron supplements. A case-control study drawing on 26,806 people with a first diagnosis of iron deficiency in a UK primary-care database found adjusted odds of 3.60 (95% CI 3.32 to 3.91) among those taking a proton pump inhibitor continuously for a year or more, and 1.51 (95% CI 1.44 to 1.58) among intermittent users [5]. A case-control study compares people who have a condition with similar people who don't, then looks back at what each group was exposed to. An odds ratio compares the two groups, with 1.0 meaning no difference, so 3.60 means continuous use was linked to about three and a half times the odds of iron deficiency, after the researchers adjusted for other factors. Both dose-response and time-response relationships were present. That study is observational, and people prescribed long-term acid suppression have upper gut disease that can itself cause iron loss, so it cannot establish cause. It should still be in the conversation, and it is the kind of contributor a dosing schedule will never overcome.
The same is true of heavy menstrual bleeding, celiac disease, inflammatory conditions, and other causes of blood loss or poor absorption. When months of iron have not raised someone's ferritin, the interval between doses is rarely what went wrong.
Dose thresholds, and why I will not give you a number
This research only applies above certain doses. In the review summarizing the whole body of work, the acute hepcidin rise that alternate-day dosing exists to avoid is triggered at oral doses of roughly 60 mg or more in iron-deficient women, and 100 mg or more in women who are already anaemic [4]. Below that threshold, spacing doses out is not wrong, and it also does not give you the advantage these trials demonstrated. A chelate is iron bound to an amino acid, such as iron bisglycinate. If you take a low-dose chelate, the studies above do not really apply to the supplement you take. That same review notes the hepcidin rise is larger after a morning dose, which makes a second dose later the same day the least useful timing of all.
This is not a self-treatment plan, and I am deliberately not giving you a number. Iron is one of the few supplements where taking too much for too long does harm, and where the right answer depends on your ferritin, your haemoglobin, your inflammatory markers, and the reason you are deficient. What you can usefully bring to your next appointment is a better set of questions. What is causing this? Has anyone looked for a source of blood loss? Does my medication list include anything that blocks absorption? And is my current schedule one I can actually stay on for six months? That last question is what the six-month trial was really testing, because adherence is where most iron plans fail.
References
Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020;105(5):1232-1239. PMID 31413088. https://doi.org/10.3324/haematol.2019.220830 (original AANP digest link: https://pubmed.ncbi.nlm.nih.gov/31413088/)
Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524-e533. PMID 29032957. https://doi.org/10.1016/S2352-3026(17)30182-5
von Siebenthal HK, Gessler S, Vallelian F, et al. Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study. EClinicalMedicine. 2023;65:102286. PMID 38021373. https://doi.org/10.1016/j.eclinm.2023.102286
Stoffel NU, von Siebenthal HK, Moretti D, Zimmermann MB. Oral iron supplementation in iron-deficient women: how much and how often? Mol Aspects Med. 2020;75:100865. PMID 32650997. https://doi.org/10.1016/j.mam.2020.100865
Tran-Duy A, Connell NJ, Vanmolkot FH, et al. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. 2018;285(2):205-214. PMID 30141278. https://doi.org/10.1111/joim.12826
A note before you go
This article is educational and is not medical advice. No dose or schedule is being recommended here. Iron deficiency has causes that need identifying, and iron taken without a reason, or continued without monitoring, can cause harm. Please do not start, stop, or restructure iron supplementation on the strength of a blog post, and do not stop a prescribed acid-suppressing medication on your own. Work it out with the clinician who ordered your labs. Written by Dr. Joyce Knieff, ND, LAc, of Yggdrasil Naturopathic.
If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.
Comments